Genomic Prediction provides advanced genetic testing for IVF. We have developed a novel, genome-wide
molecular genotyping methodology for pre-implantation genetic testing of embryos.
Our approach reduces disease risk and improves newborn health outcomes by identifying candidate
embryos for implantation which are genetically normal.
(of human disease)
When Rutgers University Associate Professor Dr. Nathan Treff co-founded Genomic Prediction
earlier this year
to help couples undergoing fertility treatments test their embryos for chromosomal
ⓖSEQ is in validation in partner labs across the world, having been tested to work equally well in other labs as on our own MiSeq sequencer. More collaborators welcome!
Genomic Prediction is engaged in a number of academic collaborations across the world. Our first embryo research collaboration has completed a first phase, successfully genotyping and karyotyping research embryo biopsies.